Dr. Reddy's Laboratories
168 hedge funds and large institutions have $1.3B invested in Dr. Reddy's Laboratories in 2014 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 62 increasing their positions, 50 reducing their positions, and 13 closing their positions.
100% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 13
24% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 50
6% more funds holding
Funds holding: 159 → 168 (+9)
1.98% more ownership
Funds ownership: 73.92% → 75.89% (+2%)
1% less capital invested
Capital invested by funds: $1.31B → $1.3B (-$17.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$41.8M |
| 2 |
CCM
Causeway Capital Management
Los Angeles,
California
|
+$22.9M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$17.5M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$12.4M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
+$8.35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
-$51.7M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$30.6M |
| 3 |
AG
Ashmore Group
London,
United Kingdom
|
-$10.8M |
| 4 |
Credit Agricole
Montrouge Cedex,
France
|
-$5.84M |
| 5 |
BAM
Baring Asset Management
London,
United Kingdom
|
-$4.78M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
176
Barclays
London,
United Kingdom
| – | -$204K | -19,580 | Closed |
|
|
LOCC
177
Lombard Odier & Cie (Canada)
Montreal,
Quebec, Canada
| – | -$44K | -4,150 | Closed |
|
|
PG
178
PEAK6 Group
Chicago,
Illinois
| – | -$19K | -1,850 | Closed |
|
|
CTC
179
Central Trust Company
Jefferson City,
Missouri
| – | -$8K | -740 | Closed |
|
|
BRWA
180
B. Riley Wealth Advisors
Boca Raton,
Florida
| – | +$421 | +40 | New |
|
|
FHA
181
First Horizon Advisors
Memphis,
Tennessee
| – | +$895 | +85 | New |
|
RDY Hedge Fund Activity: Q4 2014 in Review
168 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q4 2014, worth a combined $1.3B — down 1.4% from $1.31B a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new RDY positions and 13 closed out — a net gain of 13 holders — while 62 added to existing stakes and 50 trimmed.
The largest buyer was AQR Capital Management, adding an estimated $41.8M. The largest seller was Fidelity International, cutting an estimated $51.7M.
- 168 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q4 2014, up from 159 in Q3 2014.
- Funds reported $1.3B of Dr. Reddy's Laboratories stock for Q4 2014, down 1.4% quarter-over-quarter.
- 26 funds opened new Dr. Reddy's Laboratories positions in Q4 2014 and 13 closed out, a net change of +13 holders.
- The largest Dr. Reddy's Laboratories buyer in Q4 2014 was AQR Capital Management, an estimated $41.8M added.
- The largest Dr. Reddy's Laboratories seller in Q4 2014 was Fidelity International, an estimated $51.7M sold.
Based on aggregated 13F filings for Q4 2014.